Decompensated Heart Failure

• CLINICAL_TRIALS research · 2010-04-28
  Clinical Trial Update: Registry for Acute Decompensated Heart Failure Patients Admitted to the ER

  A registry-based trial update shows completion of a study enrolling acute decompensated heart failure patients admitted through the emergenc…

• CLINICAL_TRIALS trial_result · 2010-04-28
  Clinical Trial Update: Longitudinal Registry for Advanced Heart Failure Patients

  This entry reports a completed longitudinal registry study of patients with advanced heart failure, sponsored by Scios, Inc.

• FDA approval · 2010-01-21
  FDA Approved: MILRINONE LACTATE IN DEXTROSE — Original Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved Hikma Pharmaceuticals USA Inc.'s Milrinone Lactate in Dextrose as an Original Application (ANDA 090038), establishing a gen…

• CLINICAL_TRIALS trial_result · 2009-10-09
  Clinical Trial Update: PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function [Phase 3]

  Phase 3 trial PROTECT-2 evaluated KW-3902, a selective A1 adenosine receptor antagonist, in patients hospitalized with acute heart failure a…

• CLINICAL_TRIALS withdrawal · 2009-07-20
  Clinical Trial Update: A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure [Phase 1]

  The Phase 1 study of ularitide for acute decompensated heart failure has been withdrawn.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2009-03-25
  Clinical Trial Update: Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF) [Phase 2]

  Phase 2 trial evaluating the hemodynamic effects, safety, and tolerability of CD-NP in patients with stabilized acute heart failure has comp…

• FDA approval · 2008-02-27
  FDA Approved: MILRINONE LACTATE IN DEXTROSE — Supplemental Application (Baxter Healthcare Corporation)

  FDA approved Baxter's supplemental application for milrinone lactate in dextrose under the ANDA pathway.

• CLINICAL_TRIALS research · 2007-11-19
  Clinical Trial Update: Does Lung Impedance Correlate With Changes in BNP in Stable and Acutely Decompensated Heart Failure Patients?

  ClinicalTrials.gov update describing a study that tests whether lung impedance correlates with changes in BNP in patients with stable and ac…